Evidence map›Paper›PMID 38688472›Full record

ArticleInternational journal of immunopathology and pharmacology

Resveratrol promotes the differentiation of human umbilical cord mesenchymal stem cells into esophageal fibroblasts via AKT signaling pathway.

Xiujing Chen, Zihao Sun, Qian Wu, Lijuan Shao, Jiaxin Bei, Yiguang Lin, Hongjie Chen, Size Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xiujing ChenDepartment of Immuno-Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Zihao SunDepartment of Immuno-Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Qian WuDepartment of Immuno-Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Lijuan ShaoDepartment of Immuno-Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Jiaxin BeiDepartment of Immuno-Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Yiguang LinDepartment of Immuno-Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.ORCID 0000-0002-4637-9701
Hongjie ChenDepartment of Traditional Chinese Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Size ChenDepartment of Immuno-Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
First Affiliated Hospital of Guangdong Pharmaceutical University · CNGuangdong Pharmaceutical University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell DifferentiationEsophagusFibroblastsMesenchymal Stem CellsProto-Oncogene Proteins c-aktResveratrolSignal TransductionUmbilical CordCaspase 9Cells, CulturedCoculture TechniquesCollagenHumansInterleukin-6PhosphorylationTransforming Growth Factor betaCaspase 9CollagenInterleukin-6Proto-Oncogene Proteins c-aktResveratrolTransforming Growth Factor betaAKTco-cultureesophageal fibroblastsresveratrolstem cellumbilical cord mesenchymal stem cells

Identifiers

PMID38688472
PMCPMC11062234
OpenAlexW4396524044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.